Snapshot

The Sanitary Registration of Orphan Medicines pathway has been developed by the Instituto de Salud Pública de Chile of Chile.

This pathway can be used where Does not specify types.

It is an abridged review (a reliance pathway).

When relevant, the agency relies on prior decisions from EU-EMA United States

Target time assessment is Review times: 6 - 12 months..